Cadence Design Exceeds Expectations, Eyes Growthby Lilu Anderson 13.02.2024Cadence Design Systems reports strong Q4 results, surpassing analyst estimates for earnings per share and revenue. The company's stock has ...
Is Pandoshi the Future of Crypto? Expert Predictions Say Yes!by John Darbie 13.02.2024Pandoshi is set to disrupt the world of digital currencies with its decentralized finance approach. The project's presale has seen ...
SpaceX’s Starship Rocket Set for March Test Flightby Lilu Anderson 12.02.2024SpaceX's Elon Musk confirms that the Starship rocket is set for a test flight in March, a crucial milestone in ...
Crypto Whales Shift $350M as Bitcoin, Ethereum Soarby John Darbie 12.02.2024Wealthy crypto investors are moving $350 million in digital assets, mainly in Bitcoin and Ethereum. This suggests high activity and ...
GOP Concerns Over FDIC Fintech Policies: Transparency Neededby Mark Eisenberg 12.02.2024Three Republican members of the House Financial Services Committee have expressed concerns about the FDIC's policies on financial technology and ...
Pinterest’s Price Target Cut: Buy or Bye?by Mark Eisenberg 12.02.2024Pinterest Inc's price target has been reduced by Argus, but the Buy rating on the stock is maintained. The company's ...
Dogecoin’s Price Potential: Breakout or Breakdown?by John Darbie 12.02.2024Dogecoin, the largest meme coin, could break out of its trading range with support at $0.075 and resistance at $0.088. ...
Vertex Pharmaceuticals: Biotech Titan’s Bold Leapby Mark Eisenberg 12.02.2024Vertex Pharmaceuticals is capturing the attention of investors with its expansion into pain management and cell/gene therapies. With positive earnings ...
Intuitive Machines: Stock Surge Ahead of Lunar Questby Lilu Anderson 12.02.2024Intuitive Machines' stock soars as it prepares for a historic moon mission. A successful landing would be a major achievement ...
NRx Pharmaceuticals: $5M Boost for NRX-101 Drugby Mark Eisenberg 12.02.2024NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...